SCHEMBL7413097

SCHEMBL7413097

Nc1cc(O)c(C(=O)O)cc1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ PTGS2 P35354 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ PTPN1 P18031 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ TNF P01375 1/20 0.48
▸ HSPD1 P10809 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ CASP1 P29466 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ KDR P35968 1/20 0.48
▸ BRCA1 P38398 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ CASP7 P55210 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31444251 0.83 KDM4E (0.52) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL9478732 0.82 AKR1C4 (0.50) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL2138202 0.82 ALDH1A1 (0.56) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL29214415 0.80 KDM4E (0.54) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL29592373 0.80 GPR35 (0.49) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL382803 0.80 GPR35 (0.49) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL3675267 0.80 KMT2A (0.54) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL30121151 0.80 KMT2A (0.54) KDM4EALDH1A1CYP3A4MAPTPTGS2
SCHEMBL2985505 0.80 CA1 (0.53) KDM4EALDH1A1CYP3A4MAPTPTGS2
Water SCHEMBL3706268 0.78 GPR35 (0.47) KDM4EALDH1A1CYP3A4MAPTPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4935511-A Nervous system, gastrointestinal disorders RORER PHARMACEUTICAL CORPORATION (US) 1990-06-19 — — US disclosed
Send feedback